multiple sclerosis

News

Stronger Label for Biogen's Tysabri

Yahoo/Zacks.com

»

Login or register to post comments

News

Copaxone 15-Year Study In Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy And Safety

Medical News Today

»

Login or register to post comments

News

Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain

WSJ Online

»

Login or register to post comments

News

Teva, Active extend pact on oral MS therapy

Marketwatch

»

Login or register to post comments

News

Acorda's MS Drug May Not Be the Windfall Investors Expect

Seeking Alpha

»

Login or register to post comments

News

FDA approves Biogen Idec multiple sclerosis treatment Ampyra

Bizjournals.com

»

Login or register to post comments

News

What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)

Wall Street Journal

»

Login or register to post comments

News

Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed

Yahoo/Business Wire

»

Login or register to post comments

News

Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS

Bloomberg

»

Login or register to post comments

News

Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent

Yahoo/AP

»

Login or register to post comments